Recombinant respiratory syncytial virus vaccine( (CHO Cell)) (Chengdu Huarenkang/Shanghai Maikekang)

重组呼吸道合胞病毒疫苗（CHO细胞）（成都华任康/上海迈科康）

Report date: 2026/03/17 20:00:15

Base Information

Drug NameRecombinant respiratory syncytial virus vaccine( (CHO Cell)) (Chengdu Huarenkang/Shanghai Maikekang)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLower Respiratory Tract InfectionsRespiratory Syncytial Virus InfectionsHerpes Zoster
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChengdu Huarenkang Biological Technology Co LtdShanghai Maikekang Biological Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChengdu Huarenkang Biological Technology Co LtdShanghai Maikekang Biological Technology Co LtdMaxvax Biotechnology LLC
Inactive CompaniesN/A
Active IndicationsLower Respiratory Tract InfectionsRespiratory Syncytial Virus InfectionsHerpes Zoster
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A